Omnicell, Inc. Stock News

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference.

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering.

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes.

Omnicell, Inc. is a pharmacy management provider working towards the goal of an autonomous pharmacy. Q3 earnings looked weak on the surface with revenue and EBITDA down, but results by business show a strong and growing service business. Omnicell has unique technology with strong market tailwinds that support long-term growth.

Omnicell, Inc. (NASDAQ:OMCL ) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants Kathleen Neiman - Senior Vice President, Investor Relations Randall Lipps - Founder, Chairman, President & Chief Executive Officer Nchacha Etta - Executive Vice President & Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Jessica Tassan - P...

Omnicell stock broke out Wednesday after the medications management company obliterated its own earnings expectations. The post Omnicell Catapults And Breaks Out After Obliterating Profit Expectations appeared first on Investor's Business Daily.

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Third Quarter 2024 Results.

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Third Quarter 2024 Financial Results on October 30, 2024.